Orthofix Medical Q2 EPS $(0.88), Sales $198.60M Beat $195.23M Estimate
Portfolio Pulse from Benzinga Newsdesk
Orthofix Medical reported a Q2 EPS of $(0.88) and sales of $198.60 million, beating the estimate of $195.23 million.
August 06, 2024 | 11:05 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Orthofix Medical reported a Q2 EPS of $(0.88), which is a loss, but their sales of $198.60 million beat the estimate of $195.23 million.
Despite reporting a loss per share, Orthofix Medical's sales exceeded expectations, which is a positive indicator for the company's revenue performance. This could lead to a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100